ArticleTransplantation2016

Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.

Evangelos CholongitasPubMed ↗Publisher ↗

No numbers read from the abstract.